menu
    • menu

    Company profile for Onchilles Pharma

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Onchilles Pharma was founded on breakthrough research that was the first to describe that human neutrophils release a major anticancer protein, called ELANE, that broadly and selectively activates cell death pathways in cancer cells. This fundamental pathway of the innate immune system has the potential for universal anti-cancer activity, independent of genetic mutation. Based on this research, Onchilles is developing a pipeli...
    Onchilles Pharma was founded on breakthrough research that was the first to describe that human neutrophils release a major anticancer protein, called ELANE, that broadly and selectively activates cell death pathways in cancer cells. This fundamental pathway of the innate immune system has the potential for universal anti-cancer activity, independent of genetic mutation. Based on this research, Onchilles is developing a pipeline of first-in-class biologic drug candidates with the potential to be broadly effective against a wide range of cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Onchilles PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9880 Campus Point Drive, Suite 420 San Diego, California 92121
    Telephone
    Telephone
    (202) 256-4334
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://onchillespharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/onchillespharma/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/onchilles

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Onchilles Pharma Presents NEU-002 Data at AACR Meeting
    Onchilles Pharma Presents NEU-002 Data at AACR Meeting

    17 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260317618230/en/Onchilles-Pharma-to-Present-New-Preclinical-Data-on-Systemically-Delivered-NEU-002-Program-at-AACR-2026

    BUSSINESSWIRE
    17 Mar 2026
    Share Share
    Onchilles Pharma Secures IND for Next-Gen ELANE Cytotoxic N17350
    Onchilles Pharma Secures IND for Next-Gen ELANE Cytotoxic N17350

    02 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260202527484/en/Onchilles-Pharma-Announces-IND-Clearance-for-N17350-Advancing-the-First-Next-Generation-Cytotoxic-Therapeutic-Leveraging-the-ELANE-Pathway-into-the-Clinic

    BUSINESSWIRE
    02 Feb 2026
    Share Share
    Onchilles Publishes ELANE Pathway Study And Advances N17350
    Onchilles Publishes ELANE Pathway Study And Advances N17350

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251107100720/en/Onchilles-Pharma-Publishes-Landmark-ELANE-Pathway-Study-and-Advances-N17350-Toward-the-Clinic-With-New-Financing-and-Leading-Clinical-Advisor

    BUSINESSWIRE
    07 Nov 2025
    Share Share
    Onchilles Pharma Presents New Data at AACR 2025 on N17350
    Onchilles Pharma Presents New Data at AACR 2025 on N17350

    25 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250425701875/en/Onchilles-Pharma-Presents-New-Data-at-AACR-2025-Highlighting-N17350-a-Next-Generation-Cytotoxic-Therapeutic-Leveraging-the-ELANE-Pathway

    BUSINESSWIRE
    25 Apr 2025
    Share Share
    Onchilles Advances ELANE Pathway Pan-Cancer Therapeutics
    Onchilles Advances ELANE Pathway Pan-Cancer Therapeutics

    13 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250113083088/en

    BUSINESSWIRE
    13 Jan 2025
    Share Share
    Onchilles Pharma Presents Data on NEU-002 for ELANE Pathway at SITC
    Onchilles Pharma Presents Data on NEU-002 for ELANE Pathway at SITC

    07 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241107381437/en

    BUSINESSWIRE
    07 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search